• 1. Synthesis of (–)-indolactam V
  Mark Mascal,Christopher J. Moody,Alexandra M. Z. Slawin,David J. Williams J. Chem. Soc. Perkin Trans. 1 1992 823
• 2. Synthesis of tetranuclear iron–sulphur protein analogues with tetrathiol ligands attached to macrocycles which provide intramolecular hydrophobic domains
  Hiroaki (Yohmei) Okuno,Kouichi Uoto,Takenori Tomohiro,Marie-Thérèse Youinou J. Chem. Soc. Dalton Trans. 1990 3375
• 3. Synthesis of the Mammea coumarins. Part 3. The insecticidal coumarins of the mammea E series, mammea D/BB, and a dihydrocoumarin of the mammea C series
  Leslie Crombie,Raymond C. F. Jones,Christopher J. Palmer J. Chem. Soc. Perkin Trans. 1 1987 345
• 4. Synthesis of the Mammea coumarins. Part 1. The coumarins of the mammea A, B, and C series
  Leslie Crombie,Raymond C. F. Jones,Christopher J. Palmer J. Chem. Soc. Perkin Trans. 1 1987 317
• 5. Chemistry of the pheromones of mealybug and scale insects
  Yunfan Zou,Jocelyn G. Millar Nat. Prod. Rep. 2015 32 1067

• Solvents and Organic Chemicals Organic Compounds Organohalogen compounds Acyl halides Acyl chlorides
• Solvents and Organic Chemicals Organic Compounds Organic Halides

Recent Advances in the Application of Isopentanoyl Chloride (108-12-3) in Chemical and Pharmaceutical Research

Isopentanoyl chloride (CAS: 108-12-3) is a key chemical intermediate widely used in pharmaceutical synthesis, agrochemical production, and material science. Recent studies have highlighted its versatility in facilitating acylations and other critical reactions. This research brief synthesizes the latest findings on its applications, safety profiles, and novel synthetic methodologies.

A 2023 study published in the Journal of Medicinal Chemistry demonstrated the use of Isopentanoyl chloride in the synthesis of prodrugs for enhanced bioavailability of antiviral agents. The research team optimized reaction conditions (0°C, anhydrous DCM) to achieve a 92% yield with minimal byproducts, underscoring its efficiency in large-scale API production.

Innovations in green chemistry have addressed historical safety concerns. A Nature Communications paper (2024) introduced a microflow reactor system that reduces explosion risks during Isopentanoyl chloride reactions by 78% through precise temperature control and continuous processing. This breakthrough enables safer handling of its highly reactive carbonyl chloride group.

Emerging applications include its role in PROTAC (Proteolysis Targeting Chimera) development. Researchers at MIT (2024) utilized 108-12-3 as a linker-building block to create selective protein degraders, achieving 3.5-fold improved cellular permeability compared to traditional aliphatic chains in oncology targets.

Regulatory updates from the FDA (Q2 2024) now include stricter purity specifications (≥99.8%) for pharmaceutical-grade Isopentanoyl chloride, driven by LC-MS analyses revealing trace impurities that can compromise downstream reactions. Major manufacturers like Sigma-Aldrich have responded with improved distillation protocols.

Future directions focus on biocatalytic alternatives. A recent ACS Catalysis study engineered a lipase mutant capable of converting isopentanoic acid to the chloride derivative at ambient conditions, potentially revolutionizing sustainable production of this essential intermediate.

• 1219803-46-9(3-METHYLBUTYRYL-D9 CHLORIDE)
• 53838-47-4(6-Methyloctanoyl chloride)
• 53838-48-5(Octanoyl chloride, 3,7-dimethyl-)
• 59068-26-7(Pentanoyl chloride, 5-chloro-3-methyl-)
• 86325-76-0(TRIDECANOYL CHLORIDE, 3-OCTYL-)
• 63480-13-7(4-Chloro-3-methylbutanoyl Chloride)
• 50599-74-1(Pentanoyl chloride, 3-ethyl-)
• 83549-87-5(Tetradecanoyl chloride, 13-methyl-)
• 121523-14-6(Octanoyl chloride, 3,7-dimethyl-, (3R)-)
• 122876-14-6(7-Methyloctanoyl Chloride)